Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 49

Results For "MEA"

1113 News Found

Ashland diagnostic films medical device facilities achieve ISO certification
Diagnostic Center | April 21, 2023

Ashland diagnostic films medical device facilities achieve ISO certification

Gafchromic films support patient care in oncology


Top 20 global biopharma companies report 3.4% fall in market cap in Q1 2023: GlobalData
News | April 21, 2023

Top 20 global biopharma companies report 3.4% fall in market cap in Q1 2023: GlobalData

Bayer reported the highest market capitalization growth of 23.1% during Q1 2023


Takeda showcases digital health solutions at G20 Meeting in India
News | April 20, 2023

Takeda showcases digital health solutions at G20 Meeting in India

Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting


Molbio Diagnostics and SigTuple join hands to build next-gen diagnostic testing devices
Diagnostic Center | April 17, 2023

Molbio Diagnostics and SigTuple join hands to build next-gen diagnostic testing devices

The blood test market worldwide is today around $75-80 billion


G 20: 2nd Health Working Group Meeting discusses global collaboration in research and regional manufacturing for diagnostics
News | April 17, 2023

G 20: 2nd Health Working Group Meeting discusses global collaboration in research and regional manufacturing for diagnostics

The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics


Moderna and Merck announce an investigational individualized neoantigen therapy
Diagnostic Center | April 17, 2023

Moderna and Merck announce an investigational individualized neoantigen therapy

mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients


NS Pharma announces FDA clearance to initiate phase II study for an Exon 44 skipping candidate
Drug Approval | April 15, 2023

NS Pharma announces FDA clearance to initiate phase II study for an Exon 44 skipping candidate

Study efficacy measures will include the expression of dystrophin protein and motor function.


Digital Health: An opportunity to increase health equity
Digitisation | April 14, 2023

Digital Health: An opportunity to increase health equity

Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%


Mandaviya visits RML, reviews mock drill for ensuring COVID readiness
Public Health | April 11, 2023

Mandaviya visits RML, reviews mock drill for ensuring COVID readiness

Urges everyone to follow COVID Appropriate Behaviour and curb any misinformation


Inflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, says GlobalData
News | April 08, 2023

Inflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, says GlobalData

FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop